QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NASDAQ:USXF

iShares ESG Advanced MSCI USA ETF (USXF) Price, Holdings, & News

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free USXF Stock Alerts
$41.53
-0.69 (-1.63%)
(As of 03:59 PM ET)
Compare
Today's Range
$41.43
▼
$42.29
50-Day Range
$41.92
▼
$45.23
52-Week Range
$32.32
▼
$45.47
Volume
51,451 shs
Average Volume
83,466 shs
Market Capitalization
$919.89 million
Assets Under Management
$937.13 million
Dividend Yield
1.16%
Net Expense Ratio
0.10%
Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media
USXF stock logo

About iShares ESG Advanced MSCI USA ETF (NASDAQ:USXF)

The iShares ESG Advanced MSCI USA ETF (USXF) is an exchange-traded fund that is based on the MSCI USA Choice ESG Screened index. The fund tracks an index of large- and mid-cap US equities screened for positive environmental, social and governance rating while also screening for involvement in controversial activities. USXF was launched on Jun 16, 2020 and is managed by BlackRock.

USXF Stock Price History

USXF ETF News Headlines

April 11, 2024 | americanbankingnews.com
iShares ESG Advanced MSCI USA ETF (NASDAQ:USXF) Short Interest Update
April 1, 2024 | seekingalpha.com
USXF: Beating Its ESG Peers In 2024
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
March 24, 2024 | msn.com
iShares ESG Advanced MSCI USA ETF declares quarterly distribution of $0.1057
December 1, 2023 | ca.finance.yahoo.com
iShares ESG Equity ETF Portfolio (GEQT.TO)
December 1, 2023 | finance.yahoo.com
iShares ESG Advanced MSCI USA ETF (USXF)
November 26, 2023 | finance.yahoo.com
iShares Trust - iShares ESG Advanced MSCI USA ETF (USXFCL.SN)
November 15, 2023 | ca.finance.yahoo.com
iShares ESG Advanced MSCI USA Index ETF (XUSR.TO)
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
October 9, 2023 | theglobeandmail.com
Closing Bell: Ishares ESG Advanced MSCI USA Index ETF up on Friday (XUSR)
See More Headlines
Receive USXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares ESG Advanced MSCI USA ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares ESG Advanced MSCI USA ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:USXF
Inception Date
6/16/2020
Fund Manager
Rachel Aguirre, Jennifer Hsui, Alan Mason, Greg Savage, Amy Whitelaw
Web
N/A
Phone
14089961010

Fund Focus

Asset Class
Equity
Benchmark
MSCI USA Choice ESG Screened Index (USD)
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
North America
Number of Holdings
372

Fund Statistics

Assets Under Management
$937.12 million
Average Daily Volume
$0.00
Discount/Premium
-0.02%

Administrator, Advisor and Custodian

Administrator
Citibank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
Citibank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
Flow Traders

Options

Optionable
N/A
Short Interest
27,300 shs

Miscellaneous

Outstanding Shares
22,150,000
Beta
1.03
Creation Unit
50,000
Creation Fee
$614.00
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Ad Behind the Markets
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

iShares ESG Advanced MSCI USA ETF Expenses

TypeUSXFTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.10%0.57%0.54%0.48%0.51%
Other Expenses0.00%0.72%0.54%0.34%0.58%
Total Expense0.10%0.72%0.70%0.58%0.70%
Fee Waiver0.00%-0.76%-0.55%-0.22%-0.57%
Net Expense0.10%0.59%0.60%0.54%0.58%

iShares ESG Advanced MSCI USA ETF (USXF) Holdings & Exposure

Top 10 USXF Holdings

USXF Sector Exposure

USXF Industry Exposure

Full Holdings Details

USXF ETF - Frequently Asked Questions

How have USXF shares performed in 2024?

iShares ESG Advanced MSCI USA ETF's stock was trading at $39.82 at the beginning of the year. Since then, USXF stock has increased by 4.3% and is now trading at $41.53.
View the best growth stocks for 2024 here.

Are investors shorting iShares ESG Advanced MSCI USA ETF?

iShares ESG Advanced MSCI USA ETF saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 40,400 shares, an increase of 147.9% from the March 15th total of 16,300 shares. Based on an average trading volume of 100,500 shares, the short-interest ratio is currently 0.4 days.
View iShares ESG Advanced MSCI USA ETF's Short Interest.

How often does iShares ESG Advanced MSCI USA ETF pay dividends? What is the dividend yield for iShares ESG Advanced MSCI USA ETF?

iShares ESG Advanced MSCI USA ETF declared a quarterly dividend on Wednesday, March 20th. Stockholders of record on Friday, March 22nd will be paid a dividend of $0.1057 per share on Wednesday, March 27th. This represents a $0.42 annualized dividend and a yield of 1.02%. The ex-dividend date is Thursday, March 21st.
Read our dividend analysis for USXF.

What does USXF invest in?

iShares ESG Advanced MSCI USA ETF is a equity fund issued by iShares. USXF focuses on theme investments and follows the MSCI USA Choice ESG Screened Index (USD). The fund's investments total to approximately $937.13 million assets under management.

What stocks does iShares ESG Advanced MSCI USA ETF hold?

USXF invests in 372 holdings. Some of the stocks in their portfolio include NVIDIA (NVDA), Broadcom (AVGO), Visa (V), Mastercard (MA), Home Depot (HD), Advanced Micro Devices (AMD), Linde (LIN), Adobe (ADBE), Caterpillar (CAT) and QUALCOMM (QCOM).

What is the management fee for iShares ESG Advanced MSCI USA ETF?

iShares ESG Advanced MSCI USA ETF's management fee is 0.10% and has no other recorded expenses or fee waivers. The net expense ratio for USXF is 0.10%.

Who are iShares ESG Advanced MSCI USA ETF's major shareholders?

iShares ESG Advanced MSCI USA ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Park Avenue Securities LLC (1.78%), Optas LLC (0.36%), GenWealth Group Inc. (0.31%), Atwater Malick LLC (0.21%), Skyline Advisors Inc. (0.13%) and Austin Private Wealth LLC (0.12%).

How do I buy shares of iShares ESG Advanced MSCI USA ETF?

Shares of USXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:USXF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media